TP53 and neoplasm: Therefore, when a TP53 variant is identified within a minor fraction of sequencing reads derived from blood, it is imperative to consider the clinical presentation and relevant aspects of the medical history, including prior treatments and the presence of metastases, and to attest the presence of the variant within the tissue of origin of the tumor.